Advisory Services Network’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-382
Closed -$20.1K – 4379
2026
Q1
$20.1K Buy
+382
New +$15.7K ﹤0.01% 3196

Other funds holding TERN

Advisory Services Network's TERN Position: Q2 2026 in Review

Advisory Services Network sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 382 shares — an estimated $20.1K sold.

Advisory Services Network first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $20.1K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Advisory Services Network reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 382 Terns Pharmaceuticals shares in Q2 2026, an estimated $20.1K.
  • Advisory Services Network first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Advisory Services Network's Terns Pharmaceuticals position peaked at $20.1K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.